UK Consensus Document

   The UK Consensus document (see link below) can provide US clinicians with a definitive, reliable, scientifically-based overview of HAE genetics, pathophysiology, diagnosis, and treatment. Of course, C1INH concentrate is not licensed in the United States, so those sections of the document are of interest, but not relevant.

Click Here To Read The UK Consensus Document

UK Consensus Document In Adobe PDF Format






























HAEA.org is supported by grants from the following biotechnology companies:


















HAEA.org is supported by grants from the following biotechnology companies:
CSL Behring, Dyax Corporation, Genzyme Corporation, Jerini AG, Lev Pharmaceuticals, and Pharming NV